Role of inflammation in retinal vein occlusion.
BACKGROUND
Inflammation measured by using highly sensitive C-reactive protein (hs-CRP) may be a separate risk factor in retinal vein occlusion (RVO).


METHODS
In a small consecutive pilot case series, hs-CRP was measured in 11 patients with RVO.


RESULTS
Levels ranged from 1.0 to 18.0 mg/L (mean 6.5 [SD 6.1] mg/L), with >3.0 mg/L being considered high risk for developing vascular disease.


CONCLUSIONS
The new role of hs-CRP is important for ophthalmologists because of its part in vascular disease.
Lee
H B Harold
HB
Mayo Clinic, Department of Ophthalmology, Rochester, MN 55905, USA.
Pulido
Jose S
JS
McCannel
Colin A
CA
Buettner
Helmut
H
D000368:Aged; D000369:Aged, 80 and over; D002097:C-Reactive Protein / Q000378:metabolism; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications; D006973:Hypertension / Q000150:complications; D007249:Inflammation / Q000097:blood / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D012170:Retinal Vein Occlusion / Q000097:blood / Q000503:physiopathology*
D002097:C-Reactive Protein